Company: CMND
Filing Date: 2025-01-22
Form Type: 20-F
Source: 0001213900-25-005490
Chunk: 258

Company: Clearmind Medicine Inc.
Filing Date: 2025-01-22
Form: 20-F
Item: Item 19
Chunk 258
---
 capital is an unlimited number of common shares without par value share. As of October 31, 2024, 4,265,186 (as of October 31, 2023 – 607,337) common shares were i...  
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  On September 30, 2022 and                                                                                                             
  November 28, 2023, the Company effected 1-for-30 share consolidations of its issued and outstanding common shares. All share amounts  
  and instruments convertible into common shares prior to the date of the reverse share splits have been retroactively restated for     
  all periods presented.                                                                                                                
 ────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  Share                                                 
  transactions during the year ended October 31, 2024:  
 ────────────────────────────────────────────────────────

  (i)      On November 6, 2023, 45 common shares with a fair value of $ 117 were issued to providers of investor services in payment of services.  

  (ii)      Between December 1, 2023 and December 11, 2023, April 2023 Warrants and September 2023 Warrants were exercised into 1,062,188 common shares, resulting in gross proceeds of $ 3,498,032.  

  (iii)      On January 16, 2024, the Company completed a registered direct offering and concurrent private placement of (i) 1,468,000 Common Shares, (ii) 32,000 pre-funded warrants to purchase 32,000 Commo...  

  (iv)      On February 19, 2024, 44 common shares with a fair value of $ 68 were issued to providers of investor services in payment of services.  

  (v)      During the period between February 26, 2024 and March 26, 2024, April 2023 Warrants, September 2023 Warrants and January 2024 Warrants were exercised into 131,914 common shares, for gross proce...  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────

  (vi)      On April 3, 2024,